Request to Join
has invited you to join this group
The Internet of Things (IoT) encompasses the connections between sensors and devices and patients and clinicians. How would you use IoT to improve diagnosis, treatment, monitoring or patient care in the areas of Neuromodulation, Cardiac Rhythm Management, Cardiology, Electrophysiology, Peripheral Interventions, Oncology, Endoscopy , Urology or Pelvic Health? (#CPCIoT)
The Internet of Things (IoT) encompasses the connections between sensors and devices and patients and clinicians. How would you use IoT to improve diagnosis, treatment, monitoring or patient care...Read More
Dr. Majmudar is a practicing cardiologist and Associate Director of the Healthcare Transformation Lab at Massachusetts General Hospital, and an Instructor at Harvard Medical School. He is an active member of the healthcare innovation and entrepreneurship community, with a specific interest in technology-enabled healthcare innovation. He was a founding member and chief clinical officer of Quanttus, Inc. a venture-backed medical wearables startup. He is also a lecturer in the Harvard-MIT HST Program, and co-faculty for the course Healthcare Ventures.
Pediatric cardiologist and interventional electrophysiologist with an entrepreneurial bent--Chief Medical Officer at Genetesis, Inc., a machine learning enabled cardiac diagnostics company using cardiac magnetic field data to enable rapid diagnosis of acute ischemia. Expertise in the applications of mobile health devices (including models of implantable devcies) and digital health platforms. Clinician with understanding of physician and patient perspectives on technology, medical devices, and the challenges of the current healthcare environment. Advisor to companies offering emerging electrophysiology technology, digital health and data analytic solutions for healthcare. Author of multiple review articles and briefs on digital health and the challenges of physician engagement.
Mr. Scalzo is a clinical operations professional with extensive experience in telemedicine, managed care, patient engagement, and clinical pathway development. He currently leads clinical program design for the OCG Clinical Services Division of American Well. Mr. Scalzo holds a Bachelor of Arts with Honors in Biological Sciences and Premedical Studies from The University of Chicago and a Masters in Clinical Epidemiology and Biostatistics from The Boston University School of Public Health. His passion is driving better patient outcomes by designing evidenced-based care pathways for medical technology systems.
Kenneth Stein, MD, FACC, FHRS, is currently Senior Vice President and Chief Medical Officer
for Rhythm Management and Global Health Policy at Boston Scientific.
Ken is a Phi Beta Kappa graduate of Harvard College (in Economics), and earned his MD from New
York University School of Medicine. He completed his medical internship and residency at The New
York-Presbyterian Hospital/Weill Cornell Medical Center, where he also completed his cardiology and
cardiac electrophysiology training.
Prior to joining Boston Scientific in 2009, Dr. Stein held the position of Associate Director of Clinical
Cardiac Electrophysiology at Weill Cornell Medical Center and Associate Professor of Medicine at
Cornell University where he was widely published, authoring over 125 peer-reviewed scientific
publications in the areas of cardiac electrophysiology with special interest in cardiac resynchronization
therapy and risk stratification for sudden cardiac arrest.
Dr. Stein currently oversees the clinical trials, medical safety, and medical education and clinical
communications for Boston Scientific’s Cardiac Rhythm Management, Electrophysiology and Watchman
Left Atrial Appendage Closure businesses as well as leading the corporate Global Health Policy team
tasked with shaping the company’s policies with respect to global health care delivery and
Dr. Stein serves on the board of the Boston Scientific Political Action Committee and on the Scientific
Advisory Board of Optum Labs. Since 2013, he has also served on the board of Childrens HeartLink, a
registered 501c(3) nonprofit organization that trains and mentors medical teams in underserved parts of
the world to diagnose and treat children with heart disease. Founded in 1969, Children's HeartLink
currently supports partner hospitals in Brazil, China, India, Malaysia, Ukraine and Vietnam.
Dipanjan Banerjee, MD, MS is a cardiologist trained in advanced heart failure and cardiac transplantation, with a primary interest in patients with end stage heart failure. In his clinical practice he cares for patients with heart failure, mechanical heart-assist devices, and heart transplantation both in the coronary care unit (CCU) and in the outpatient clinic. His research interests are clinical, and primarily involve improving outcomes in patients with left ventricular assist devices (LVAD) and the use of digital health technology. Regarding the latter, he has conducted studies to determine whether digital health technology can reduce readmission rates in patients with heart failure hospitalizations, and capture the rate of recovery in paitents after LVAD placement. Currently, he is part of a multi center trial sponsored by the American Heart Association (AHA) trying to determine whether digital health technology can improve the lives of patients with diabetes and heart failure (TARGET-HF).
Sanjeev Bhavnani MD is a cardiologist and physician-scientist in healthcare innovation and practice transformation at Scripps Clinic and Research Foundation. Dr. Bhavnani was a Qualcomm Wireless Health Scholar at TSRI where he was involved in the design of next generation digital medicine clinical trials. As a principle investigator on several studies, he has designed trials using nanosensors, wireless mHealth and smartphone-connected devices, handheld ultrasound, lab-on-a-chip technologies and cloud-based data platforms across various patient populations, and to assess the impact of new technologies on healthcare quality, costs, and outcomes. These trials have been executed across the US and in resource limited areas – Uganda, India, and Mexico – where he and his team have designed the first smartphone-connected mHealth clinics . To date, these mHealth clinics have enrolled 20,000+ patients. Dr. Bhavnani works with teams of clinicians, researchers, biomedical engineers, translational informatics, and biostatisticians. He serves on the innovation advisory boards of several national medical societies and has worked with digital health think tanks to develop the CONNECT legislation and 21st Century Cures Act. He is board certified in internal medicine, cardiovascular diseases, nuclear cardiology, echocardiography, and clinical informatics, and has been recognized as a 'Top Doc' and 40-under-40 life science innovators in San Diego.
Ami B. Bhatt is the director of the Adult Congenital Heart Disease Center at MGH and an active clinical cardiologist, investigator and educator. She innovates in the cardiology space at the MGH Heart Center in the domains of telemedicine for patient visits, adolescent education, multimodality teleconferences, and adoption of mobile health technologies. Her work has most recently centered on applying design thinking to the multidisciplinary care process creating transparent systems for coordinating and achieving patient and physician centric care, emphasizing that the two are not mutually exclusive. Her interest in digital health strategy stems from her beliefs that state of the art, personalized care can be delivered to individuals in the community and that “concierge” style medicine is possible for everyone. In her recent promotion to Director of Outpatient Services within Cardiology at the MGH, she is working with patient and family advocates, MGH administration, and design teams on their outpatient care model. The MGH Healthcare Transformation Lab is home to her creative side, and allows her the space to innovate with partners from different domains. When she’s not busy innovating, she spends time with her husband and two daughters, having dance parties and traveling.